Thalidomide-O-amido-PEG2-C2-NH2 TFA (Synonyms: Cereblon Ligand-Linker Conjugates 10 TFA; E3 Ligase Ligand-Linker Conjugates 24 TFA) |
| Catalog No.GC33847 |
Thalidomide-O-amido-PEG2-C2-NH2 TFA est un conjugué ligand-linker E3 ligase synthétisé qui incorpore le ligand cereblon À base de thalidomide et le linker PEG À 2 unités utilisé dans la technologie PROTAC.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1957235-75-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
E3 Ligase Ligand-Linker Conjugates 24 (TFA) incorporates an E3 ligase ligand and a linker, can be an immunomodulater for the treatment of cancer.
[1]. ARYL SULFONOHYDRAZIDES. WO 2017/176958 A1.
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *